6 results about "Susceptibility testing" patented technology

The utility model discloses a metal hot crack sensitivity detection device, relates to the technical field of metal casting, and aims to solve the problem of lack of a metal hot crack sensitivity detection device for molten metal in the prior art. The casting cavity is communicated with a sprue, ring iron is arranged in the casting cavity, the ring iron and the casting cavity are concentrically arranged, the width of the ring iron is the same as that of the casting cavity, and the diameter of the ring iron is smaller than that of the casting cavity; a chilling block is arranged at the bottom of the casting cavity, and the upper surface of the chilling block and the bottom face of the casting cavity are arranged at the same height.

The utility model provides a kit for rapidly identifying and culturing drug sensitivity of salmonella, and relates to the field of salmonella culture. The salmonella rapid identification culture drug sensitivity kit comprises a kit body and a kit cover, a container used for culturing salmonella is fixedly installed in the kit body, a base plate is fixedly installed on the inner bottom wall of the container, a telescopic rod used for rotating is fixedly connected to the base plate, a filter screen and an arc-shaped plate are fixedly installed at the movable end of the telescopic rod, and the arc-shaped plate is fixedly connected with the filter screen. The filter screen is slidably connected with the container; the rapid identification and culture drug sensitivity kit for salmonella integrates sample separation, dynamic culture and drug sensitivity test, after culture is completed, a drug sensitivity reagent can be directly added for the drug sensitivity test, sample transfer is not needed, operation steps and time are reduced, rapid identification and drug sensitivity detection of salmonella are achieved, and the kit is suitable for large-scale popularization and application. And the detection efficiency and accuracy are improved.

Methods for identifying bacterial species in biofluid samples (e.g., whole blood samples) are described. The methods rely on optical spectroscopy, and enable rapid detection and identification of bacteria directly from whole blood. Not only can LSS-based techniques detect and identify bacteria in biofluids such as whole blood, but that species-level identification can potentially be made based on a small number of bacterial cells, without the need for observing entire colonies or performing susceptibility testing. The methods may comprise illuminating the biofluid sample with input light, detecting scattered light produced by the biofluid sample in response to the illuminating, generating first data indicative of a measured scattering spectrum associated with the biofluid sample using the detected scattered light, and identifying whether at least one of the bacterial species is present in the biofluid sample using the first data.

A sealing microlid (novel microplate sealing lid) designed to evaluate the biological effects of volatile agents in vapour phase in combination with a microplate is disclosed. The sealing microlid includes a plate having a surface, a plurality of flanges extending from the surface, and a protruding opening tab. The flanges of the sealing microlid serve as reservoirs for growth medium containing organisms or cells, which will grow on it, and, at the same time, generate an airtight condition with the well of the microplate necessary for leakage-prevention of the volatile agents tested. The apparatus of the present invention allows quantitative, rapid, simple, labour-and cost-effective susceptibility testing of organism or cell cultures to volatile agents in vapour phase.

Methods are presented which use impedance flow cytometry for rapid susceptibility testing of antimicrobial agents including phage, antimicrobial peptides and rapid analysis of antimicrobial mediated serum bactericidal assays.

This invention discloses a pan-drug-resistant strain of *Pseudomonas aeruginosa* PAS96 and its applications. *Pseudomonas aeruginosa* PAS96 has the accession number GDMCC No: 64767. This bacterium is resistant to levofloxacin, ciprofloxacin, piperacillin, piperacillin / tazobactam, ticarcillin / clavulanic acid, ceftazidime, meropenem, and imipenem. This invention confirmed the resistance of *Pseudomonas aeruginosa* to the aforementioned antibiotics through Kirby-Bauer (K-B) susceptibility testing.